Months 6-12 : Continued steady weight loss with proper adherence
Preclinical studies in mice demonstrate reduced atherosclerotic plaque progression and increased plaque stability
Pantanetti P, Cangelosi G, Alberti S, Di Marco S, Michetti G, Cerasoli G, Di Giacinti M, Coacci S, Francucci N, Petrelli F, Ambrosio G, Grinta R (2024) Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice
You can review available NAD IV dosage options, learn what to expect during treatment, or schedule an in-clinic or mobile NAD IV therapy appointment at a time that fits your schedule using the link below
Graper Harper Cosmetic Surgery (GHCS) proudly offers a cutting-edge GLP-1/GIP-based weight management program designed to help you achieve real, lasting results
Kalmbacher today to learn more about AOD 9604 and other effective weight loss solutions